Losartan clinical trials angiotensin-receptor blockers

Losartan Monopotassium Salt - Losartan Potassium - DuP753 - DuP 753 - DuP-753 - MK954 - MK 954 - MK-954 - Cozaar - Losartan

Acute myocardial infarction

1 trials  - OPTIMAAL

Atrial fibrillation

1 trials  - LIFE (AF ancillary study)

Diabetes type 2

All type of patients:  1 trials  - RENAAL

Patients with hypertension:  1 trials  - LIFE (diabetic subgroup)

Patients with or without hypertension:  2 trials  - LIFE (diabetic subgroup) - RENAAL

Diabetic kidney disease

1 trials  - RENAAL

Heart failure

All type of patients:  11 trials  - HEAAL - ELITE II - Hamroff et al. - ELITE - Lang et al. - Losartan phase II S - losartan phase II US - Losartan Phase III International - Dickstein et al. - Losartan Phase III U.S. - NCT00090259

Patients already receiving ACE inhibitor:  3 trials  - Hamroff et al. - Lang et al. - Dickstein et al.

Patients previously untreated with ACE inhibitors:  2 trials  - ELITE II - ELITE

Hypertension

All diseases requiring ACEi (HF, CHD, HT,...):  5 trials  - LIFE - OPTIMAAL - RENAAL - ELITE-II - ELITE

All type of patient:  2 trials  - LIFE - RENAAL

Diabetic patients :  2 trials  - LIFE (diabetic subgroup) - RENAAL

Patients with additional risk factor:  1 trials  - LIFE

Miscellaneous

2 trials  - LIFE - RENAAL

Patients at high risk for cardiovascular events

2 trials  - LIFE - RENAAL